Effectiveness of Per-Operative Bupivicaine in Reducing Postoperative Pain at Port Site and Improving Mobility in Knee Arthoscopic Procedures

ConditionArthroscopic Surgery

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18-70

SponsorKhyber Teaching Hospital

About this trial

The investigator's aim is to evaluate the effectiveness of per-operative bupivacaine infiltration at arthroscopic port sites in reducing post-operative pain compared to placebo in patients undergoing knee arthroscopic procedures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

5 ml of 0.5% bupivacaine infiltrated at each port site
Drug
5 ml of 0.5% bupivacaine infiltrated at each port site after the arthroscopic procedures
Placebo
Drug
5ml 0.9%normal saline infiltrated at port site

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: Intervention groupExperimental treatment 1 intervention

Group B: Control groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

Postoperative Port Site Pain Score

Pain will be measured using the Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst pain), at the port site following knee arthroscopy.

Time frame

6 hours, 12 hours, and 24 hours postoperatively

Secondary outcomes

Proportion of Patients Achieving Early Mobility

Early mobility is defined as the ability to perform prescribed physical therapy exercises and ambulate (with assistance from a caregiver or ambulatory aids) within 6 hours after knee arthroscopic surgery. This will be recorded as a binary outcome (Yes/No) based on physiotherapist evaluation

Time frame

Assessed after 6 hours of completion of procedure

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Khyber Teaching Hospital

Lead sponsor

Source ClinicalTrials.gov

Apply now